Splenogenic anemia

Splenogenic anemia is a group of blood diseases characterized by a decrease in the concentration of hemoglobin in the blood and associated with disruption of the spleen. This may be due to various reasons, including infectious diseases, autoimmune processes, malignant neoplasms and other factors.

Splenogenic anemia can manifest itself with various symptoms, such as weakness, fatigue, dizziness, shortness of breath, pale skin and mucous membranes, as well as decreased appetite and weight loss. With a long course of the disease, complications may develop, such as heart failure, thrombosis, etc.

To diagnose splenogenic anemia, a blood test is performed to determine the level of hemoglobin and other indicators. Additional research methods may also be used, such as ultrasound examination of the spleen, computed tomography, etc. Treatment depends on the cause of the disease and may include the use of medications, blood transfusions, or surgery.

Splenogenic anemia is a serious disease that requires timely treatment. If you notice symptoms of splenogenic anemia in yourself or your loved ones, consult a doctor for diagnosis and treatment.

Splenic anemia is an outdated term for symptomatic anemia that develops in women during menopause due to a decrease in the formation of estrogen, leading to liver atrophy and inhibition of hematopoiesis in the bone marrow. However, according to the modern definition, anemia is a consequence of pathological blood loss in the patient (due to bleeding) or the physiological state of the body - chronic hemolytic anemia, etc.

The term "Splenosplenomegaly" is a condition in which the size of the spleen becomes larger than normal. This can be caused by various reasons. For example, some people may have splenomegaly from birth and not experience any symptoms. Other people may acquire splenomegaly due to injury, infection, tumor, or other disease